We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Hit With Class Action Suit Over OTC Zantac Labeling
Pfizer Hit With Class Action Suit Over OTC Zantac Labeling
A group of consumers filed a class action suit against Pfizer, alleging that the company knew or should have known that its over-the-counter heartburn drug Zantac (ranitidine) was contaminated with dangerous levels of NDMA and unsafe for consumption.